{"id":"https://openalex.org/W2017477151","doi":"https://doi.org/10.1016/j.hemonc.2013.11.003","title":"Efficacy and safety of sorafenib-gemcitabine combination therapy in advanced hepatocellular carcinoma: An open-label Phase II feasibility study","display_name":"Efficacy and safety of sorafenib-gemcitabine combination therapy in advanced hepatocellular carcinoma: An open-label Phase II feasibility study","publication_year":2013,"publication_date":"2013-12-12","ids":{"openalex":"https://openalex.org/W2017477151","doi":"https://doi.org/10.1016/j.hemonc.2013.11.003","mag":"2017477151","pmid":"https://pubmed.ncbi.nlm.nih.gov/24333135"},"language":"en","primary_location":{"id":"doi:10.1016/j.hemonc.2013.11.003","doi":"https://doi.org/10.1016/j.hemonc.2013.11.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.hemonc.2013.11.003","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1658387613000952/pdf","source":{"id":"https://openalex.org/S2898422462","display_name":"Hematology/Oncology and Stem Cell Therapy","issn_l":"2589-0646","issn":["2589-0646","1658-3876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology/Oncology and Stem Cell Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017477151"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.sciencedirect.com/science/article/pii/S1658387613000952/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058370086","display_name":"Naeem Naqi","orcid":"https://orcid.org/0000-0002-8024-6179","observed_orcids":["https://orcid.org/0000-0002-8024-6179"]},"institutions":[{"id":"https://openalex.org/I2800672702","display_name":"Combined Military Hospital","ror":"https://ror.org/05mya2w74","country_code":"PK","type":"healthcare","lineage":["https://openalex.org/I2800672702"]}],"countries":["PK"],"is_corresponding":true,"raw_author_name":"Naeem Naqi","raw_affiliation_strings":["Combined Military Hospital and Medical College, Lahore Cantt, Pakistan. Electronic address: naeemnaqi@hotmail.com","Combined Military Hospital and Medical College, Lahore Cantt, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Combined Military Hospital and Medical College, Lahore Cantt, Pakistan. Electronic address: naeemnaqi@hotmail.com","institution_ids":[]},{"raw_affiliation_string":"Combined Military Hospital and Medical College, Lahore Cantt, Pakistan","institution_ids":["https://openalex.org/I2800672702"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035934048","display_name":"Shaharyar Ahmad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142016965","display_name":"King Edward Medical University","ror":"https://ror.org/02rrbpf42","country_code":"PK","type":"education","lineage":["https://openalex.org/I142016965"]},{"id":"https://openalex.org/I4210145659","display_name":"Mayo Hospital","ror":"https://ror.org/046jyn221","country_code":"PK","type":"healthcare","lineage":["https://openalex.org/I4210145659"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Shaharyar Ahmad","raw_affiliation_strings":["Mayo Hospital, King Edward Medical University, Lahore, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Hospital, King Edward Medical University, Lahore, Pakistan","institution_ids":["https://openalex.org/I142016965","https://openalex.org/I4210145659"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sohail Murad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405261697","display_name":"Institute of Nuclear Medicine and Oncology Lahore","ror":"https://ror.org/05q3bvy68","country_code":"PK","type":"government","lineage":["https://openalex.org/I1324877311","https://openalex.org/I4405261697"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Sohail Murad","raw_affiliation_strings":["Institute of Nuclear Medicine and Oncology, Lahore, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Nuclear Medicine and Oncology, Lahore, Pakistan","institution_ids":["https://openalex.org/I4405261697"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079681264","display_name":"Javaid Khattak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800672702","display_name":"Combined Military Hospital","ror":"https://ror.org/05mya2w74","country_code":"PK","type":"healthcare","lineage":["https://openalex.org/I2800672702"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Javaid Khattak","raw_affiliation_strings":["Combined Military Hospital, Rawalpindi, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Combined Military Hospital, Rawalpindi, Pakistan","institution_ids":["https://openalex.org/I2800672702"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5058370086"],"corresponding_institution_ids":["https://openalex.org/I2800672702"],"apc_list":null,"apc_paid":null,"fwci":0.7078,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.70844894,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"7","issue":"1","first_page":"27","last_page":"31"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9649999737739563},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/advanced-hepatocellular-carcinoma","display_name":"advanced hepatocellular carcinoma","score":0.9049999713897705},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8209999799728394},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.6980000138282776},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.640999972820282},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9419999718666077},{"id":"https://openalex.org/keywords/hand-foot-skin-reaction","display_name":"hand-foot skin reaction","score":0.9419999718666077},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.7080000042915344},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.933323323726654},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.8514752388000488},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.8328129053115845},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6483330726623535},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.60202956199646},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.552208662033081},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.45757269859313965},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.13156825304031372},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0789414644241333},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003710","descriptor_name":"Demography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005240","descriptor_name":"Feasibility Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.hemonc.2013.11.003","doi":"https://doi.org/10.1016/j.hemonc.2013.11.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.hemonc.2013.11.003","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1658387613000952/pdf","source":{"id":"https://openalex.org/S2898422462","display_name":"Hematology/Oncology and Stem Cell Therapy","issn_l":"2589-0646","issn":["2589-0646","1658-3876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology/Oncology and Stem Cell Therapy","raw_type":"journal-article"},{"id":"pmid:24333135","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24333135","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology/oncology and stem cell therapy","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:doaj.org/article:9a33e9b1a6214bca91233e113927ca3b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9a33e9b1a6214bca91233e113927ca3b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology/Oncology and Stem Cell Therapy, Vol 7, Iss 1, Pp 27-31 (2014)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.hemonc.2013.11.003","doi":"https://doi.org/10.1016/j.hemonc.2013.11.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.hemonc.2013.11.003","pdf_url":"https://www.sciencedirect.com/science/article/pii/S1658387613000952/pdf","source":{"id":"https://openalex.org/S2898422462","display_name":"Hematology/Oncology and Stem Cell Therapy","issn_l":"2589-0646","issn":["2589-0646","1658-3876"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology/Oncology and Stem Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320320303","display_name":"Bayer HealthCare","ror":"https://ror.org/04hmn8g73"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017477151.pdf","grobid_xml":"https://content.openalex.org/works/W2017477151.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1857440086","https://openalex.org/W1971837077","https://openalex.org/W1988298330","https://openalex.org/W1994193851","https://openalex.org/W2020830322","https://openalex.org/W2046667245","https://openalex.org/W2056527566","https://openalex.org/W2099774889","https://openalex.org/W2106602049","https://openalex.org/W2106787323","https://openalex.org/W2138610774","https://openalex.org/W2152746495","https://openalex.org/W2155152791","https://openalex.org/W2159112333","https://openalex.org/W3139763557"],"related_works":["https://openalex.org/W1834073560","https://openalex.org/W2248852318","https://openalex.org/W2590180764","https://openalex.org/W2018026948","https://openalex.org/W2228084160","https://openalex.org/W2927166132","https://openalex.org/W2950559964","https://openalex.org/W2780523994","https://openalex.org/W2621190609","https://openalex.org/W2007018893"],"abstract_inverted_index":{"PURPOSE:":[0],"Sorafenib":[1],"is":[2,176],"considered":[3],"a":[4,17,42,55,108],"standard":[5],"of":[6,41,107,125,171,203],"care":[7],"in":[8,28,47,64,200],"advanced":[9,29,50,204],"hepatocellular":[10],"carcinoma":[11],"(HCC).":[12],"Its":[13],"combination":[14,46,174,197],"with":[15,20,49,76,84,95],"gemcitabine,":[16],"pyrimidine":[18],"analogue":[19],"limited":[21],"friendly":[22],"hepatic":[23],"profile":[24],"may":[25],"prove":[26],"beneficial":[27],"HCC.":[30,51,205],"The":[31,146,169],"primary":[32],"objective":[33],"was":[34,54,142],"to":[35,178,188],"evaluate":[36],"the":[37,116,179,201],"efficacy":[38,170],"and":[39,44,73,104,136,164,192],"safety":[40],"sorafenib":[43,85,172,180],"gemcitabine":[45,96,173],"patients":[48,69,118,128],"METHODS:":[52],"This":[53],"non-randomized,":[56],"open-label,":[57],"single-arm,":[58],"multi-centric":[59],"Phase":[60],"II":[61],"study":[62],"conducted":[63],"Pakistan":[65],"where":[66],"30":[67],"treatment-naive":[68],"aged":[70],"between":[71],"26":[72],"73":[74],"years":[75],"Child-Pugh":[77],"score":[78],"A":[79],"or":[80],"B":[81],"were":[82,154],"treated":[83],"(400":[86],"mg":[87],"oral)":[88],"twice":[89],"daily":[90],"for":[91,111],"16":[92,112],"weeks":[93],"along":[94],"(1000":[97],"mg/m(2)":[98],"intravenous)":[99],"administered":[100],"on":[101],"day":[102,105],"1":[103],"8":[106],"four-week":[109],"cycle":[110],"weeks.":[113],"RESULTS:":[114],"Of":[115],"18":[117],"(60%)":[119],"who":[120],"completed":[121],"all":[122],"four":[123],"cycles":[124],"treatment,":[126],"eight":[127,137],"had":[129,133,138],"stable":[130],"disease,":[131],"two":[132],"partial":[134],"response,":[135],"progressive":[139],"disease.":[140],"There":[141],"no":[143],"complete":[144],"response.":[145],"most":[147],"common":[148],"(\u226510%":[149],"patients)":[150],"treatment-emergent":[151],"adverse":[152],"events":[153],"gemcitabine-related":[155,189],"thrombocytopenia":[156],"(40%)":[157],"followed":[158],"by":[159],"sorafenib-related":[160],"hand-foot":[161],"skin":[162],"reaction":[163],"anorexia":[165],"(33%":[166],"each).":[167],"CONCLUSION:":[168],"therapy":[175,198],"similar":[177],"alone":[181],"treatment.":[182],"However,":[183],"frequent":[184],"dose":[185],"adjustments":[186],"due":[187],"toxicities,":[190],"delays,":[191],"corrective":[193],"treatments":[194],"make":[195],"this":[196],"unsafe":[199],"treatment":[202]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}
